Related references
Note: Only part of the references are listed.The tissue inhibitor of metalloproteinases-1 improves migration and adhesion of hematopoietic stem and progenitor cells
C. Matthias Wilk et al.
EXPERIMENTAL HEMATOLOGY (2013)
A crucial role for Lyn in TIMP-1 erythroid cell survival signalling pathway
Lucie Bridoux et al.
FEBS LETTERS (2013)
Cell surface engineering of renal cell carcinoma with glycosylphosphatidylinositol-anchored TIMP-1 blocks TGF-β1 activation and reduces regulatory ID gene expression
Susan Notohamiprodjo et al.
BIOLOGICAL CHEMISTRY (2012)
Overexpression of TIMP-1 in Embryonic Stem Cells Attenuates Adverse Cardiac Remodeling Following Myocardial Infarction
Carley Glass et al.
CELL TRANSPLANTATION (2012)
Is tissue inhibitor of metalloproteinase-1 a new prognosticator for breast cancer? An analysis of 266 cases
Alessandro Neri et al.
HUMAN PATHOLOGY (2012)
Plasma levels of matrix metalloproteinases and their inhibitors in hypertension: a systematic review and meta-analysis
Chiara Marchesi et al.
JOURNAL OF HYPERTENSION (2012)
TIMP-1 Induces an EMT-Like Phenotypic Conversion in MDCK Cells Independent of Its MMP-Inhibitory Domain
Young Suk Jung et al.
PLOS ONE (2012)
Nitric Oxide Synthase and Breast Cancer: Role of TIMP-1 in NO-mediated Akt Activation
Lisa A. Ridnour et al.
PLOS ONE (2012)
Tissue inhibitor of metalloproteinase-1 (TIMP-1) regulates mesenchymal stem cells through let-7f microRNA and Wnt/β-catenin signaling
Virginia Egea et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
Silencing tissue inhibitors of metalloproteinases (TIMPs) with short interfering RNA reveals a role for TIMP-1 in hepatic stellate cell proliferation
Andrew J. Fowell et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2011)
Novel biomarkers in human terminal heart failure and under mechanical circulatory support
Frank Kramer et al.
BIOMARKERS (2011)
TIMP-1 deficiency subverts cell-cycle dynamics in murine long-term HSCs
Lara Rossi et al.
BLOOD (2011)
Elevated Plasma Tissue Inhibitor of Metalloproteinase-1 Levels Predict Decreased Survival in Castration-Resistant Prostate Cancer Patients
William K. Oh et al.
CANCER (2011)
Tissue inhibitor of metalloproteinases-1-induced scattered liver metastasis is mediated by hypoxia-inducible factor-1α
Florian Schelter et al.
CLINICAL & EXPERIMENTAL METASTASIS (2011)
Tumor cell-derived Timp-1 is necessary for maintaining metastasis-promoting Met-signaling via inhibition of Adam-10
Florian Schelter et al.
CLINICAL & EXPERIMENTAL METASTASIS (2011)
Plasma Markers for Identifying Patients with Metastatic Melanoma
Harriet M. Kluger et al.
CLINICAL CANCER RESEARCH (2011)
Tissue inhibitor of metalloproteinase-1 promotes NIH3T3 fibroblast proliferation by activating p-Akt and cell cycle progression
Yang Lu et al.
MOLECULES AND CELLS (2011)
Tissue inhibitors of metalloproteinases
Gillian Murphy
GENOME BIOLOGY (2011)
Usefulness of Plasma Tissue Inhibitors of Metalloproteinases as Markers of Prognosis After Acute Myocardial Infarction
Dominic Kelly et al.
AMERICAN JOURNAL OF CARDIOLOGY (2010)
The tissue inhibitors of metalloproteinases (TIMPs): An ancient family with structural and functional diversity
Keith Brew et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH (2010)
Matrix Metalloproteinases: Regulators of the Tumor Microenvironment
Kai Kessenbrock et al.
CELL (2010)
Tissue inhibitor of metalloproteinase-1 protects MCF-7 breast cancer cells from paclitaxel-induced apoptosis by decreasing the stability of cyclin B1
Ting Wang et al.
INTERNATIONAL JOURNAL OF CANCER (2010)
Down-regulation of Tissue Inhibitor of Metalloproteinase-3 (TIMP-3) Expression Is Necessary for Adipocyte Differentiation
Denis Bernot et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
Bone Loss Induced by Runx2 Over-Expression in Mice Is Blunted by Osteoblastic Over-Expression of TIMP-1
Corinne Schiltz et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2010)
TIMPs and cardiac remodeling: 'Embracing the MMP-independent-side of the family'
Davy Vanhoutte et al.
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2010)
High levels of serum TIMP-1 correlate with advanced disease and predict for poor survival in patients with multiple myeloma treated with novel agents
Evangelos Terpos et al.
LEUKEMIA RESEARCH (2010)
The prognostic value of TIMP-1 in multiple myeloma
Liliana Guedez et al.
LEUKEMIA RESEARCH (2010)
Blood Vessel Density in De Novo Formed Adipose Tissue Is Decreased Upon Overexpression of TIMP-1
Ilse Scroyen et al.
OBESITY (2010)
Tissue Inhibitor of Metalloproteinase-3 (TIMP-3) Regulates Hematopoiesis and Bone Formation In Vivo
Yi Shen et al.
PLOS ONE (2010)
Peritumoral administration of GPI-anchored TIMP-1 inhibits colon carcinoma growth in Rag-2 γ chain-deficient mice
Matthias C. Raggi et al.
BIOLOGICAL CHEMISTRY (2009)
TIMP-1 overexpression promotes tumorigenesis of MDA-MB-231 breast cancer cells and alters expression of a subset of cancer promoting genes in vivo distinct from those observed in vitro
Rebecca L. H. Bigelow et al.
BREAST CANCER RESEARCH AND TREATMENT (2009)
Signal transduction by focal adhesion kinase in cancer
Jihe Zhao et al.
CANCER AND METASTASIS REVIEWS (2009)
TIMP-1-GPI in combination with hyperthermic treatment of melanoma increases sensitivity to FAS-mediated apoptosis
Roghieh Djafarzadeh et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2009)
MicroRNAs: Target Recognition and Regulatory Functions
David P. Bartel
CELL (2009)
Trafficking and function of the tetraspanin CD63
Maaike S. Pols et al.
EXPERIMENTAL CELL RESEARCH (2009)
TIMP-1 binding to proMMP-9/CD44 complex localized at the cell surface promotes erythroid cell survival
Elise Lambert et al.
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2009)
Low expression of tissue inhibitor of metalloproteinases-1 (TIMP-1) in glioblastoma predicts longer patient survival
Charlotte Aaberg-Jessen et al.
JOURNAL OF NEURO-ONCOLOGY (2009)
Neuronal TIMP-1 Release Accompanies Astrocytic MMP-9 Secretion and Enhances Astrocyte Proliferation Induced by β-Amyloid 25-35 Fragment
Mar Hernandez-Guillamon et al.
JOURNAL OF NEUROSCIENCE RESEARCH (2009)
A New Role for TIMP-1 in Modulating Neurite Outgrowth and Morphology of Cortical Neurons
Adlane Ould-yahoui et al.
PLOS ONE (2009)
TIMP-1 as a tumor marker in breast cancer - An update
Sidse O. Wuertz et al.
ACTA ONCOLOGICA (2008)
Plasma TGF-beta(1), TIMP-1, MMP-1 and IL-18 as a combined biomarker of psoriasis activity
Iwona Flisiak et al.
BIOMARKERS (2008)
TIMP1 induces CD44 expression and the activation and nuclear translocation of SHP1 during the late centrocyte/post-germinal center B cell differentiation
Young-Sik Kim et al.
CANCER LETTERS (2008)
Blood sampling affects circulating TIMP-1 concentration, a useful biomarker in estimating liver fibrosis stages
Ferdinando Mannello et al.
HEPATOLOGY (2008)
Inhibition of osteoblastic metalloproteinases in mice prevents bone loss induced by oestrogen deficiency
Corinne Schiltz et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2008)
Progress in matrix metalloproteinase research
Gillian Murphy et al.
MOLECULAR ASPECTS OF MEDICINE (2008)
The ADAM metalloproteinases
Dylan R. Edwards et al.
MOLECULAR ASPECTS OF MEDICINE (2008)
Tissue Inhibitors of Metalloproteinases in Cell Signaling: Metalloproteinase-Independent Biological Activities
William G. Stetler-Stevenson
SCIENCE SIGNALING (2008)
The tumor microenvironment: regulation by MMP-independent effects of tissue inhibitor of metalloproteinases-2
William G. Stetler-Stevenson
CANCER AND METASTASIS REVIEWS (2008)
Tissue inhibitor of metalloproteinases-1 promotes liver metastasis by induction of hepatocyte growth factor signaling
Charlotte Kopitz et al.
CANCER RESEARCH (2007)
Factors released from embryonic stem cells inhibit apoptosis of H9c2 cells
Dinender K. Singla et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2007)
MMP-2, MTI-MMP, and TMP-2 are essential for the invasive capacity of human mesenchymal stem cells: differential regulation by inflammatory cytokines
Christian Ries et al.
BLOOD (2007)
Matrix metalloproteinases and the regulation of tissue remodelling
Andrea Page-McCaw et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2007)
Wnt/β-catenin signaling in development and disease
Hans Clevers
CELL (2006)
Identification of CD63 as a tissue inhibitor of metalloproteinase-1 interacting cell surface protein
Ki-Kyung Jung et al.
EMBO JOURNAL (2006)
Wnt signaling regulates the invasion capacity of human mesenchymal stem cells
Peter Neth et al.
STEM CELLS (2006)
Tissue Inhibitor of Metalloproteinase-2 (TIMP-2) expression is regulated by multiple neural differentiation signals
Diane M. Jaworski et al.
JOURNAL OF NEUROCHEMISTRY (2006)
TIMP-1 regulation of cell cycle in human breast epithelial cells via stabilization of p27KIP1 protein
M. E. Taube et al.
ONCOGENE (2006)
Tissue inhibitor of matrix metalloproteinase-1 suppresses apoptosis of mouse bone marrow stromal cell line MBA-1
L. -J. Guo et al.
CALCIFIED TISSUE INTERNATIONAL (2006)
GPI-anchored TIMP-1 treatment renders renal cell carcinoma sensitive to FAS-meditated killing
R Djafarzadeh et al.
ONCOGENE (2006)
Tissue inhibitor of metalloproteinase-2 (TIMP-2)-deficient mice display motor deficits
DM Jaworski et al.
JOURNAL OF NEUROBIOLOGY (2006)
Metalloproteinases and their inhibitors in tumor angiogenesis
MM Handsley et al.
INTERNATIONAL JOURNAL OF CANCER (2005)
Tissue inhibitor of metalloproteinase-2 promotes neuronal differentiation by acting as an anti-mitogenic signal
L Pérez-Martínez et al.
JOURNAL OF NEUROSCIENCE (2005)
Tissue inhibitor of metalloproteinase 1 is an independent predictor of prognosis in patients with nonsmall cell lung carcinoma who undergo resection with curative intent
V Gouyer et al.
CANCER (2005)
TIMP-2: an endogenous inhibitor of angiogenesis
WG Stetler-Stevenson et al.
TRENDS IN MOLECULAR MEDICINE (2005)
Tissue inhibitor of metalloproteinase 1 (TIMP-1) promotes plasmablastic differentiation of a Burkitt lymphoma cell line: implications in the pathogenesis of plasmacytic/plasmablastic tumors
L Guedez et al.
BLOOD (2005)
TIMPs as multifacial proteins
E Lambert et al.
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2004)
JNK suppresses apoptosis via phosphorylation of the proapoptotic Bcl-2 family protein BAD
CF Yu et al.
MOLECULAR CELL (2004)
Retinoids and TIMP1 prevent radiation-induced apoptosis of capillary endothelial cells
E Vorotnikova et al.
RADIATION RESEARCH (2004)
TIMP-1 inhibits microvascular endothelial cell migration by MMP-dependent and MMP-independent mechanisms
T Akahane et al.
EXPERIMENTAL CELL RESEARCH (2004)
Exogenously added GPI-anchored tissue inhibitor of matrix metal loproteinase-1 (TIMP-1) displays enhanced and novel biological activities
R Djafarzadeh et al.
BIOLOGICAL CHEMISTRY (2004)
TIMP-1 stimulates proliferation of human aortic smooth muscle cells and Ras effector pathways
T Akahane et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2004)
Tissue inhibitor of metalloproteinase 1 activates normal human granulocytes, protects them from apoptosis, and blocks their transmigration during inflammation
M Chromek et al.
INFECTION AND IMMUNITY (2004)
Tissue inhibitor of metalloproteinase-1 protects human breast epithelial cells against intrinsic apoptotic cell death via the focal adhesion kinase/phosphatidylinositol 3-kinase and MAPK signaling pathway
XW Liu et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
The expression of tissue inhibitor of metalloproteinase 2 (TIMP-2) is required for normal development of zebrafish embryos
JS Zhang et al.
DEVELOPMENT GENES AND EVOLUTION (2003)
TIMP-2 mediated inhibition of angiogenesis: An MMP-independent mechanism
DW Seo et al.
CELL (2003)
Tissue inhibitor of metalloproteinases-1 signalling pathway leading to erythroid cell survival
E Lambert et al.
BIOCHEMICAL JOURNAL (2003)
Tissue inhibitor of metalloproteinases-3 induces apoptosis in melanoma cells by stabilization of death receptors
M Ahonen et al.
ONCOGENE (2003)
A novel function for tissue inhibitor of metalloproteinases-3 (TIMP3): inhibition of angiogenesis by blockage of VEGF binding to VEGF receptor-2
JH Qi et al.
NATURE MEDICINE (2003)
Both tissue inhibitors of metalloproteinases-1 (TIMP-1) and TIMP-2 activate Ras but through different pathways
T Wang et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2002)
Inhibition of apoptosis of activated hepatic stellate cells by tissue inhibitor of metalloproteinase-1 is mediated via effects on matrix metalloproteinase inhibition - Implications for reversibility of liver fibrosis
FR Murphy et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
New functions for the matrix metalloproteinases in cancer progression
M Egeblad et al.
NATURE REVIEWS CANCER (2002)
TIMP-1 overexpression in pancreatic cancer attenuates tumor growth, decreases implantation and metastasis, and inhibits angiogenesis
M Bloomston et al.
JOURNAL OF SURGICAL RESEARCH (2002)
The low density lipoprotein receptor-related protein modulates levels of matrix metalloproteinase 9 (MMP-9) by mediating its cellular catabolism
E Hahn-Dantona et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Tissue inhibitor of metalloproteinase-1 prevents cytokine-mediated dysfunction and cytotoxicity in pancreatic islets and β-cells
X Han et al.
DIABETES (2001)
Tissue inhibitor of metalloproteinases 1 regulation of interleukin-10 in B-cell differentiation and lymphomagenesis
L Guedez et al.
BLOOD (2001)
Involvement of the p38 mitogen-activated protein kinase pathway in tissue inhibitor of metalloproteinases-1-induced erythroid differentiation
E Petitfrère et al.
FEBS LETTERS (2000)
Share Paper
